Skin Cancer
Electro-Optical Sciences Completes Patient Accrual in MelaFind® Pivotal Trial for Early Melanoma Detection
Published in Medical Letter on the CDC and FDA, August 31st, 2008
"This represents a significant milestone for the company in our quest to improve early melanoma detection," said Joseph V. Gulfo, MD, MBA, President & CEO. "We would like to thank the dedicated physicians, nurses, and staff at our clinical trial sites, and most notably, the patients for their willingness to participate in this landmark study."
MelaFind...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Hypertension
New findings reported from S.G. Chrysant and co-authors describe advances in hypertension - Immunoassay
Research on immunoassay discussed by T. Urakami and co-researchers - Life Sciences
Reports summarize life sciences research from R.G. Wenzel and co-authors - Monoclonal Antibodies
New monoclonal antibodies study findings recently were reported by researchers at University of North Texas - PolyMedix, Inc.
PolyMedix Has Regulatory Clearance to Initiate Phase I Clinical Study of Novel Anticoagulant Antagonist Compound - Regulatory Actions
Studies conducted at University of Pittsburgh on regulatory actions recently published - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
